Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Powershares Dynamic Biotechnology & Genome Portfolio

+ Add to Watchlist

PBE:US

55.6800 USD 1.2900 2.37%

As of 20:04:03 ET on 03/27/2015.

Snapshot for Powershares Dynamic Biotechnology & Genome Portfolio (PBE)

Open: 54.7200 High - Low: 55.9999 - 54.7200 Primary Exchange: NYSE Arca
Volume: 60,600 52-Week Range: 36.8800 - 59.9800 Beta vs DZOTR: 1.0035

ETF Chart for PBE

No chart data available.
  • PBE:US 55.6800
  • 1D
  • 1M
  • 1Y
54.3900
Interactive PBE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PBE

PowerShares Dynamic Biotechnology & Genome Portfolio is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index, a fundamentally-weighted index. Securities shown to possess the greatest capital appreciation potential are selected by the Index.

Inception Date: 2005-06-23 Telephone: 1-800-983-0903
Managers: PETER HUBBARD / MICHAEL JEANETTE
Web Site: www.powershares.com

Fundamentals for PBE

NAV (on 2015-03-27) 55.7352
Assets (M) (on 2015-03-27) 540.6311
Shares out (M) 9.70
Market Cap (M) 540.10
% Premium -0.10
Average 52-Week % Premium -0.0020
Fund Leveraged N

Dividends for PBE

Dividend Type Omitted
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.50%

Performance for PBE

1-Month +1.57% 1-Year +34.71%
3-Month +10.02% 3-Year +34.59%
Year To Date +10.92% 5-Year +23.51%
Expense Ratio 0.63

Top Fund Holdings for PBE

Filing Date: 03/27/2015
Name Position Value % of Total
BioMarin Pharmaceutical Inc 247,134 31,825,917 5.890%
Pharmacyclics Inc 122,544 31,439,276 5.819%
Regeneron Pharmaceuticals Inc 63,940 29,060,730 5.378%
Biogen Inc 64,603 27,770,892 5.140%
Amgen Inc 167,771 27,277,887 5.048%
Vertex Pharmaceuticals Inc 221,558 26,662,290 4.935%
Alexion Pharmaceuticals Inc 146,702 26,492,914 4.903%
Gilead Sciences Inc 255,585 25,814,085 4.778%
Repligen Corp 561,383 17,161,478 3.176%
Medivation Inc 122,803 16,209,382 3.000%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil